News Stories

The fifth annual Melanoma Walk will raise funds to fight this deadly disease and increase awareness about melanoma.

A unique collaboration between the UA Cancer Center and NAU to bring cancer prevention and biomedical research training to Native American communities in Arizona has received $13 million in additional funding.

Jessica A. Miller, PhD

Jessica A. Miller, PhD, has been awarded a three-year, $450,000 Susan G. Komen grant to investigate the cause of chronic joint stiffness and pain associated with the use of aromatase inhibitors (AI) — a class of drug often used to treat hormone receptor-positive breast cancer.

Daniel O. Persky, MD

Daniel O. Persky, MD, is one of just 12 physician scientists honored this year by the National Cancer Instititue for his leadership in clinical research.

The National Cancer Institute has renewed a grant for the Cancer Biology Graduate Interdisciplinary Program which trains cancer researchers for the future.

David S. Alberts, MD

David S. Alberts, MD, will receive the AACR's Prevention Pioneer Award during the organization's upcoming cancer prevention research conference in New Orleans.

Christina Laukaitis, MD, PhD, FACP

UA Cancer Center member Christina Laukaitis, MD, PhD, FACP, calls the proposed expansion for the use of genetic screening to identify possible risk for breast and ovarian cancer “a bold, intriguing thought that deserves more study.”

A drug to treat advanced melanoma that received fast-track approval from the Food and Drug Administration was tested at the UA Cancer Center, offering patients access to therapies not available elsewhere.

Elizabeth Calhoun, PhD, MEd

Elizabeth Calhoun, PhD, MEd, has been appointed associate vice president for population health sciences and executive director of the new Center for Population Science and Discovery at the Arizona Health Sciences Center at the University of Arizona.

Danzhou Yang and Laurence Hurley

Danzhou Yang, PhD, and Laurence Hurley, PhD, were awarded a five-year, $370,000 grant to research a novel drug-like molecule that can kill cancer cells with little to no toxicity in the body.